测试ID:PTMSC

prothrombin Time Mix 1:1, Plasma

对...有用
建议在测试可能有帮助的临床障碍或设置

screening test to detect a deficiency of 1 or more of the clotting factors of the extrinsic coagulation system (I, II, V, VII, X) due to hereditary deficiency or acquired conditions such as liver disease, vitamin K deficiency, or a specific factor inhibitor

确定延长凝血酶蛋白时间,因子缺乏与因子抑制剂的原因

方法名称
一种short description of the method used to perform the test

仅作为反射订购。有关更多信息,请参见:

一种l你pp/ Lupus Anticoagulant Profile, Plasma

ALBLD / BLEEDING DIATHESIS CRUPER,LIMITD,等离子体

一种一种tHr/ Thrombophilia Profile, Plasma

APROL /长时间的凝块时间轮廓,等离子体

ADIC/散布的血管内凝血/血管内凝结和纤维蛋白解(DIC/ICF)剖面,血浆

纽约州可用
我ndicates the status of NY State approval and if the test is orderable for NY State clients.

是的

报告名称
列出了测试的已发布名称的缩写或缩写版本

ptmix 1:1

specimen Type
描述了测试验证的样品类型

plasma Na Cit

necessary Information

应注意肝素或香豆素疗法。

需要标本
定义执行测试所需的最佳标本和首选卷以完成测试

仅作为反射订购。有关更多信息,请参见:

一种l你pp/ Lupus Anticoagulant Profile, Plasma

ALBLD / BLEEDING DIATHESIS CRUPER,LIMITD,等离子体

一种一种tHr/ Thrombophilia Profile, Plasma

APROL /长时间的凝块时间轮廓,等离子体

ADIC/散布的血管内凝血/血管内凝结和纤维蛋白解(DIC/ICF)剖面,血浆

拒绝due To
标识可能导致样品被拒绝的样品类型和条件

严重的溶血 拒绝
脂肪血症 拒绝
大黄色 拒绝

标本稳定性信息
提供了将样品运输到表演实验室所需的温度的描述,还包括可接受的温度

specimen Type 温度 时间 特殊容器
plasma Na Cit 冷冻(首选) 14天

对...有用
建议在测试可能有帮助的临床障碍或设置

screening test to detect a deficiency of 1 or more of the clotting factors of the extrinsic coagulation system (I, II, V, VII, X) due to hereditary deficiency or acquired conditions such as liver disease, vitamin K deficiency, or a specific factor inhibitor

确定延长凝血酶蛋白时间,因子缺乏与因子抑制剂的原因

Clinical Information
discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

this test is only performed when the prothrombin time (PT) is abnormally prolonged. See PTSC / Prothrombin Time (PT), Plasma for an interpretation of results.

reference Values
描述参考间隔和其他信息,以解释测试结果。可能会在适当的情况下包括基于年龄和性别的间隔。除非另有指定,否则间隔是梅奥衍生的。如果提供了解释性报告,则参考值字段将陈述。

仅作为反射订购。有关更多信息,请参见:

一种l你pp/ Lupus Anticoagulant Profile, Plasma

ALBLD / BLEEDING DIATHESIS CRUPER,LIMITD,等离子体

一种一种tHr/ Thrombophilia Profile, Plasma

APROL /长时间的凝块时间轮廓,等离子体

ADIC/散布的血管内凝血/血管内凝结和纤维蛋白解(DIC/ICF)剖面,血浆

9.4-12.5秒

解释
提供信息以帮助解释测试结果

凝结凝集素时间(PT)的延长可能是由于1或更多的凝血因子(可获得或先天性的)或存在凝结抑制剂(例如肝素,狼疮抗凝剂),一种“非特异性”抑制剂的抑制剂,可能发生。例如单克隆免疫球蛋白或特定的凝血因子抑制剂。

ptmixing study, using equal volume patient and normal pool plasma, may be performed on specimens with a prolonged PT to assist in differentiating coagulation factor deficiencies from coagulation inhibitors. Correction of the PT mix to within the normal reference range usually indicates a coagulation factor deficiency (normal plasma in the mixture ensures at least 50% activity of all coagulation factors). If the prolonged PT is due to an inhibitor (specific coagulation factor inhibitor, lupus anticoagulant, heparin, etc), the PT mix typically fails to correct a prolonged PT. However, the presence of a weak inhibitor may be missed by the PT mixing study.

对PT和PT混合研究结果的准确解释通常需要进行额外的测试。例如,凝血酶时间(TT)测试有助于识别或排除肝素的存在,血小板中和程序(PNP,使用修改后的APTT方法)用于识别或排除狼疮抗凝剂,激活的部分血栓素(APPTT)和稀释和稀释Russell Viper毒液时间(DRVVT),用于进一步评估常见的凝胶途径,以及用于检测和识别缺乏或异常因素的凝结因子测定。这些测定可作为特殊凝血实验室中反身和解释性测试面板的组成部分提供:

一种l你pp/ Lupus Anticoagulant Profile, Plasma

ALBLD / BLEEDING DIATHESIS CRUPER,LIMITD,等离子体

一种一种tHr/ Thrombophilia Profile, Plasma

APROL /长时间的凝块时间轮廓,等离子体

ADIC/散布的血管内凝血/血管内凝结和纤维蛋白解(DIC/ICF)剖面,血浆

警告
讨论可能导致诊断混乱的条件,包括不正确的标本收集和处理,不适当的测试选择以及干扰物质

prothrombin time (PT) mixing studies have no utility when the patient PT is normal.

脂肪标本可能会干扰仪器凝块检测机制。

Clinical Reference
深入阅读临床性质的建议

Kamal AH,Tefferi A,Pruthi RK:如何解释和追求异常的凝血酶原时间,激活了部分血栓形成时间和成人流血时间。Mayo Clin Proc 2007 7月:82(7):864-873

方法描述
describes how the test is performed and provides a method-specific reference

the prothrombin time (PT) mix assay is performed on the Instrumentation Laboratory ACL TOP. Patient plasma is combined in a 1:1 ratio with normal pooled plasma then incubated. After a specified incubation time, a PT reagent containing phospholipid, calcium chloride, buffer and a preservative is added to trigger the coagulation process in the mixture. Subsequently, the time to clot formation is measured optically using a wavelength of 671 nm.(Package insert: HemosIL RecombiPlasTin 2G Instrumentation Laboratory Company, Lexington, MA, R0, 09/2007)

pdFreport
指示该报告是否包含带有图表,图像或其他丰富信息的其他文档

一天表演
概述了进行测试的日子。该领域反映了样品必须在测试实验室中才能开始测试过程的一天,并包括进行测试之前的任何标本准备和处理时间。一些测试被列为连续执行的,这意味着测定在白天多次执行。

从星期一到星期五

report Available
the interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.

1至4天

标本保留时间
概述了测试样品在丢弃之前将样品保存在实验室中的时间长度

7 days

performing Laboratory Location
指示执行测试的实验室的位置

罗切斯特

费用
几个因素决定了进行测试的费用。请与您的美国或国际区域经理联系,以获取有关建立费用时间表的信息,或了解有关资源以优化测试选择的更多信息。

  • 一种uthorized users can sign in totest Prices有关详细的费用信息。
  • Clients without access to Test Prices can contact亚搏每周7天,每天24小时。
  • 潜在客户应联系其区域经理。寻求帮助,联系亚搏

test Classification
provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.

this test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT代码信息
为确定每个测试或配置文件的适当当前程序术语(CPT)代码提供指导。列出的CPT代码反映了Mayo Clinic实验室对CPTyabo208编码要求的解释。每个实验室的责任是确定用于计费的正确CPT代码。

CPT代码由表演实验室提供。

85611

lo我nC® Information
provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.

test Id 测试订单名称 订单loinc值
PTMSC ptmix 1:1 5959-2
result Id 测试结果名称 结果lainc值
仅适用于最初由表演实验室报告的度量单位表达的结果。这些值不适用于转换为其他度量单位的结果。
PTMSC ptmix 1:1 5959-2

测试设置资源

设置文件
test setup information contains test file definition details to support order and result interfacing between Mayo Clinic Laboratories and your Laboratory Information System.

Excel|Create a PDF

样本报告
不rmal and Abnormal sample reports are provided as references for report appearance.

正常报告|异常报告

SI样本报告
为有限数量的测试提供了单位报告的国际系统(SI)。这些报告旨在用于国际帐户使用,只能通过定义为接收它们的Mayolink帐户提供。

SI正常报告|s我异常报告